i48.DHRBeta-R:Journal. Risk Management: Compound .Level : PA . Time: Short-term - Intermediate . This is just my view follow if it aligns with yours. Ideas are not repeated rather updated.Worry about risk only.
DHRC trade ideas
DHR at a good spot to take riskA messy breakout here has left us with a proper opportunity on Monday morning to take some risk with a stop at the 144 spot. I'm looking at some 2mo ATM calls.
DHR: further downside potential?A confluence of technical indicators pointing to a bearish bias.
Deteriorating trend.
Downside momentum supporting a bearish trend direction.
Time to exit: +/- 21 October 2019
$154 target for Danaher CorpAfter a great start to 2019 , DHR has stalled for the past 3 months and has been in a consolidation phase, we see a short term breakout above $145.
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
DHR - BullPut SpreadWeekly Chart. W RSI is <20.
S/R at approx 135/136 Mid BB% also Daily MA100
Looking for Reversal to mean higher.
Taking 135/130 Put Credit Spread.
Also picked up 140 call for Directional Bias Higher.
Sept Exp .
Ideally Exit around RSI 50/70 from W Chart or sooner if in decent Profit. !
Good Luck - Watch your $$$ RISK
$DHR WILL BE A GREAT SHORT ON ANY MARKET WEAKNESSDespite the acquisition of GE Biopharma the stock performance this year is hard to quantify, it does seem that it has ran a little too far to fast and needs a healthy pullback. We assume that when the selling does start it could snowball into quite a drop as large profits are banked and sellers find it hard to offload their portfolio. We will be looking at this as a short when the indicators become more oversld.
AVERAGE ANALYSTS PRICE TARGET $144
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO 41
COMPANY PROFILE
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
Nuetral Daily/Sell DHR on 4 hrDaily looks like range bound consolidation
4 hour tweezer top, red outside
Yes, higher high, lower high; counter intuitive trade
Double top fractal on lower time frames... See 2hr, 1 hr, can argue for daily also.
Insiders selling strong for the month of november
Cashing our at the top... Now way... they would never!!! ;)
Zoom out and trace the diamond tops!
ATR 2.39
S/L 105.16
T/P 97.68
R/R 3.3 (play 10/30/18 gap to fill)
Profit trading!
DHR Danaher Corp. Possible 10%+ Upside Trend/Resistance line: DHR Has recently overtaken a long-term resistance trendline starting in 2010 on the weekly chart and is currently using it as a loose support trendline. The chart, on both the weekly and daily timeframes, is showing an ascending wedge, with the stock gaining momentum we should see the price move past the resistance made in the 103.60-104.00 range.
MACD (12, 26, close): The MACD indicator is showing a bullish signal on the weekly, assuming the current price action remains the same we should see this crossing be confirmed within the next two weeks. Not only does the weekly MACD look promising but the daily does as well, making higher bullish crossings, signaling increasing momentum.
RSI(14): RSI on both daily and weekly have overtaken the 50 mark, again signaling the gain of momentum, which will be vital for breaking past resistance.
FIB lines: Weekly fib lines have been marked on the chart, with the red being possible stops and green as my current price target, which loosely aligns with analyst recommendations. Daily chart supports these targets as well, although slightly lower at a price target of 108.00
DHR: I have traded this before and this is perfect time again.Nice wedge and now making a nice cup. Do not miss this name.
Thinking this:
Sept 21st: 105s
You welcome!!
DANAHER CORP. Buy OpportunityThe positive company profile and the strong structure, as well as the continuation of the bullish l market in the US stocks, indicate that a new bullish wave for the Danaher stock could start.
The break out of the triangle at 104.30 may trigger the new buy rally.
Levels as described in the chart.
Ascending TriangleAscending triangle, probably before breakout.
Worth noticing the behaviour of the health sector, which should support the move up.
Long DHR in consolidationThe daily chart of DHR looks to be in the final stages of a Wave-4 triangle. Alternation between Wave-2 and Wave-4 of the impulsive move is a good sign. This means Wave-2 was a deep, zig-zag correction compared to a shallow, sideways correction in Wave-4. A topside break of the triangle should lead to higher prices in Wave-5. Initiating a long position with an immediate profit target at 105 (with an extension up to 107.50). A move below 95 invalidates the setup.
